Načítá se...

Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) remains deadly despite advances in systemic therapies and surgical techniques. While there is increasing utilization of immune therapies across diverse cancer types, PDAC remains generally resistant to these treatments. We report a case of locally advanced PDA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: McCarthy, Patrick M, Rendo, Matthew J, Uy, Matthew D, Adams, Alexandra M, O’Shea, Anne E, Nelson, Daniel William, Fenderson, Joshua L, Cebe, Katherine M, Krell, Robert W, Clifton, Guy T, Peoples, George E, Vreeland, Timothy J
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8179799/
https://ncbi.nlm.nih.gov/pubmed/34103944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S311661
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!